The presence of KCC2 mutations in human epilepsy indicates that accumulation of intracellular Cl− secondary to KCC2 dysfunction may be responsible for driving neuronal hyperexcitability underlying the development of epilepsy syndromes. Here, SLC12A5 is linked to epilepsy syndrome.